Phrama

1 stories about Phrama
אמיר וייסברג

Controlled Drug Release Company Polypid Attempts Second Nasdaq IPO

11.02.18|Dror Reich
The Israel-based company is looking to raise up to $86.25 million to fund clinical development and trials and manufacturing activities